Dolutegravir / Lamivudine

Also known as Dovato (us)

Save $2,910/mo

66× cheaper

The combination of dolutegravir and lamivudine is used to treat human immunodeficiency virus (HIV) infection in certain people.

United States

$2,955

per month

India

$45

per month

You save

$2,910

98% cheaper in India

176.9K US scripts/yr$514.9M potential annual savings$522.8M US spend/yr

3D structure coming soon

Resolve it by running structure:fetch

Compare the price

US price$2,955per month

India price$45per month

You save$2,91098% less

Based on 30 units per month. US $98.50 vs India $1.50 per unit.

How many months / courses?

Total over 1 periodSave $2,910$2,955 → $45

Is travelling to India worth it?

The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.

Months of medicine

Round-trip flights ($)

Hotel / night ($)

Nights of stay

Extra buffer ($)

Medicine savings over 6 months: $17,460
Estimated travel cost: − $2,300
Net savings after travel: $15,160

Even after travel, you could come out ahead by about $15,160.

Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.

The bigger picture

Dolutegravir / Lamivudine is filled about 176.9K times a year under Medicare Part D. At the prices above, that works out to roughly:

Est. annual US spend

$522.8M

If sourced from India

$8M

Potential annual savings

$514.9M

−98%

Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.